Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
197
Views
13
CrossRef citations to date
0
Altmetric
Review

Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine

Sabine LindquistSection Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, GermanyCorrespondence[email protected]
&
Martin StangelSection Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany
Pages 341-349 | Published online: 30 May 2011

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yong Ling, Zhi-You Hao, Dong Liang, Chun-Lei Zhang, Yan-Fei Liu & Yan Wang. (2021) The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. Drug Design, Development and Therapy 15, pages 4289-4338.
Read now
Shin J. Oh. (2019) Amifampridine for the treatment of Lambert-Eaton myasthenic syndrome. Expert Review of Clinical Immunology 15:10, pages 991-1007.
Read now
Sabine Lindquist & Martin Stangel. (2014) 3,4-Diaminopyridine (amifampridine) for the treatment of Lambert–Eaton myasthenic syndrome. Expert Opinion on Orphan Drugs 2:3, pages 293-300.
Read now
Sarah EW Briggs, Paul Gozzard & Denis C Talbot. (2013) The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma. ImmunoTargets and Therapy 2, pages 31-37.
Read now

Articles from other publishers (9)

Yasodha Krishna Janapati, Sunithasree Cheweti, Bojjibabu Chidipi, Medidi Srinivas & Sunil Junapudi. 2023. Exploring Chemistry with Pyridine Derivatives. Exploring Chemistry with Pyridine Derivatives.
Silvia Bonanno, Riccardo Giossi, Riccardo Zanin, Valentina Porcelli, Claudio Iannacone, Giovanni Baranello, Gary Ingenito, Stanley Iyadurai, Zorica Stevic, Stojan Peric & Lorenzo Maggi. (2022) Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial. Journal of Neurology 269:11, pages 5858-5867.
Crossref
Hiroaki Yoshikawa, Yumi Adachi, Yosikazu Nakamura, Nagato Kuriyama, Hiroyuki Murai, Yoshiko Nomura, Yasunari Sakai, Kazuo Iwasa, Yutaka Furukawa, Satoshi Kuwabara & Makoto Matsui. (2022) Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan. BMJ Neurology Open 4:2, pages e000291.
Crossref
Tychicus Chen. (2021) Clinical Reasoning: A 68-Year-Old Man With Proximal Weakness and Seizures. Neurology 97:4, pages e423-e428.
Crossref
Shao-Hua Wang, Kuan Wang, Ke Zhao, Shu-Cheng Hua & Juan Du. (2020) The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C. Frontiers in Microbiology 11.
Crossref
Margarida Lorigo, Nelson Oliveira & Elisa Cairrao. (2020) Clinical Importance of the Human Umbilical Artery Potassium Channels. Cells 9:9, pages 1956.
Crossref
Connie H. Yoon, Jocelyn Owusu-Guha, Adam Smith & Pamela Buschur. (2019) Amifampridine for the Management of Lambert-Eaton Myasthenic Syndrome: A New Take on an Old Drug. Annals of Pharmacotherapy 54:1, pages 56-63.
Crossref
Kun Huang, Yue-Bei Luo & Huan Yang. (2019) Autoimmune Channelopathies at Neuromuscular Junction. Frontiers in Neurology 10.
Crossref
Nobuhiro Kanaji. (2014) Paraneoplastic syndromes associated with lung cancer Nobuhiro Kanaji, Naoki Watanabe, Nobuyuki Kita, Shuji Bandoh, Akira Tadokoro, Tomoya Ishii, Hiroaki Dobashi, Takuya Matsunaga. World Journal of Clinical Oncology 5:3, pages 197.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.